Thursday, October 12, 2017

FDA panel considers gene therapy for blindness

  1. FDA panel considers gene therapy for blindness  SFGate
  2. FDA Vote Sets Stage for Gene Therapy's Future  MIT Technology Review
  3. Experimental gene therapy for blindness considered by FDA  NBC Montana
  4. Gene therapy drug developed in Philadelphia helps people with rare hereditary blindness see  Philly.comFull coverage

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Headlines